Trademark: 97728289
Status Date
Wednesday, April 24, 2024
Filing Date
Thursday, December 22, 2022
Published for Opposition
Tuesday, August 29, 2023
41 Consultation in the field of publishing and issuing scientific papers in relation to conducting clinical trials, regulatory affairs, drug development, manufacturing compliance and validation, advanced technology, clinical benchmarking and clinical performance improvement in the field of international health and in the pharmaceutical, biotechnology, and medical device industries
9 Computer software, namely, downloadable computer programs for accessing, collecting, managing, tracking, analyzing, and reporting data and information on clinical trials, computer program systems consisting of computer hardware and recorded software systems for accessing, collecting, managing, tracking, analyzing, and reporting data and information on clinical trials and program libraries in the nature of electronic databases recorded on a data carrier in the field of pharmaceutical research and development and printed users manuals for use therewith sold as a unit
39 clinical trial logistical services, namely, delivering clinical trial kits to sites, delivering wearable devices to patients and/or site locations
38 Providing user access to a global computer network in connection with clinical trials and drug development; Provision of access to a computer network in connection with clinical trials and drug development
37 Real estate site selection namely, building inspecting in the course of building construction of potential sites for hosting clinical trials
44 Medical and pharmaceutical consultation
10 Study equipment for clinical trials, namely, patient monitors and patient sensors for monitoring and measuring health properties and respiratory events, medical instruments to measure blood pressure, cardiac output and other physiological and cardiovascular parameters, medical imaging devices for the brain, and medical apparatus for detecting cancer, for use in clinical trials
42 Inspecting potential sites for hosting clinical trials for quality control purposes
The mark consists of three Chinese characters.
The non-Latin characters in the mark transliterate to "KANG DI YA" and this has no meaning in a foreign language.
Color is not claimed as a feature of the mark.
Dec 26, 2022
New Application Entered
Jan 19, 2023
New Application Office Supplied Data Entered
Jan 20, 2023
Notice Of Design Search Code E-Mailed
May 19, 2023
Assigned To Examiner
Jun 2, 2023
Non-Final Action Written
Jun 2, 2023
Non-Final Action E-Mailed
Jun 2, 2023
Notification Of Non-Final Action E-Mailed
Jul 20, 2023
Teas Response To Office Action Received
Jul 20, 2023
Correspondence Received In Law Office
Jul 20, 2023
Teas/Email Correspondence Entered
Jul 21, 2023
Approved For Pub - Principal Register
Aug 9, 2023
Notification Of Notice Of Publication E-Mailed
Aug 29, 2023
Published For Opposition
Aug 29, 2023
Official Gazette Publication Confirmation E-Mailed
Oct 24, 2023
Noa E-Mailed - Sou Required From Applicant
Apr 24, 2024
Sou Teas Extension Received
Apr 24, 2024
Sou Extension 1 Filed
Apr 24, 2024
Sou Extension 1 Granted
Trademark Alertz updated from USPTO on 2030-01-24
